Clinical Studies Evaluating Effects of Probiotics on Parameters of Intestinal Barrier Function

Saskia van Hemert, Jurre Verwer, Burkhard Schütz

.
Winclove Probiotics, Amsterdam, the Netherlands.

DOI: 10.4236/aim.2013.32032                

Abstract

The intestinal barrier is important in preventing translocation of bacteria, toxins and antigens from the lumen of the gut into the body. Enhanced permeability, or gut leakiness, has been associated with different diseases. Probiotics can, strain-specifically, improve the epithelial barrier function. However, so far most researches have used cell lines or animal models due to the difficulty of measuring the effects of products on the epithelial barrier function in vivo in humans. Here a systematic literature search was performed to find articles addressing the effects of probiotics on the barrier function in human trials. The Pubmed database was searched (January 2013) to identify human in vivo studies with probiotic products in which parameters for epithelial barrier function were measured. In total 29 studies were identified, but patients, bacterial characteristics and methods to measure intestinal barrier function caused large heterogeneity among these studies. About half of the studies showed positive results of probiotics on the epithelial barrier function, indicating a clear potential of probiotics in this field. In a case series of 14 patients using Ecologic^a825, a probiotic food supplement with known effect on epithelial barrier function, different markers of intestinal integrity improved significantly. Further studies in this field should consider strain(s), dose and duration of the probiotic supplementation as well as the markers used to measure epithelial barrier function. Besides the lactulose/mannitol test, zonulin and α1-antitrypsin might be valuable markers to measure epithelial barrier function in future experiments.

Keywords

Bacteria; Epithelial Barrier; Gut Permeability; Intestinal Barrier Function; Intestinal Integrity; Probiotics; Review; Vivo Studies

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	A. Farhadi, A. Banan, J. Fields and A. Keshavarzian, “Intestinal Barrier: An Interface between Health and Disease,” Journal of Gastroenterology and Hepatology, Vol. 18, No. 5, 2003, pp. 479-497. doi:10.1046/j.1440-1746.2003.03032.x
[2]	A. M. Marchiando, W. V. Graham and J. R. Turner, “Epithelial Barriers in Homeostasis and Disease,” Annual Review of Pathology-Mechanisms of Disease, Vol. 5, 2010, pp. 119-144. doi:10.1146/annurev.pathol.4.110807.092135
[3]	A. Fasano, “Leaky Gut and Autoimmune Diseases,” Clinical Review of Allergy and Immunology, Vol. 42, No. 1, 2012, pp. 71-78. doi:10.1007/s12016-011-8291-x
[4]	FAO/WHO, “Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria,” 2001.
[5]	E. J. Videlock and F. Cremonini, “Meta-Analysis: Probiotics in Antibiotic-Associated Diarrhoea,” Alimentary and Pharmacology Therapy, Vol. 35, No. 12, 2012, pp. 1355-1369. doi:10.1111/j.1365-2036.2012.05104.x
[6]	K. Alfaleh, J. Anabrees, D. Bassler and T. Al-Kharfi, “Probiotics for Prevention of Necrotizing Enterocolitis in Preterm Infants,” Cochrane Database Systematic Reviews, No. 3, 2011, Article ID: CD005496. doi:10.1002/14651858.CD005496.pub3
[7]	I. R. Rowland, et al., “Current Level of Consensus on Probiotic Science-Report of an Expert Meeting-London, 23 November 2009,” Gut Microbes, Vol. 1, No. 6, 2010, pp. 436-439. doi:10.4161/gmic.1.6.13610
[8]	E. Miyauchi, et al., “Mechanism of Protection of Transepithelial Barrier Function by Lactobacillus Salivarius: Strain-Dependence and Attenuation by Bacteriocin Production,” American Journal of Physiology and Gastrointestinal Liver Physiology, Vol. 303, No. 9, 2012, pp. G1029-G1104. doi:10.1152/ajpgi.00003.2012
[9]	C. L. Ohland and W. K. Macnaughton, “Probiotic Bacteria and Intestinal Epithelial Barrier Function,” American Journal of Physiology and Gastrointestinal Liver Physiology, Vol. 298, No. 6, 2010, pp G807-G819. doi:10.1152/ajpgi.00243.2009
[10]	F. J. Penna, L. A. Peret, L. Q. Vieira and J. R. Nicoli, “Probiotics and Mucosal Barrier in Children,” Current Opinion in Clinical Nutrion and Metabolic Care, Vol. 11, No. 5, 2008, pp. 640-644. doi:10.1097/MCO.0b013e32830a70ab
[11]	R. Mennigen and M. Bruewer, “Effect of Probiotics on Intestinal Barrier Function,” Annals of the New York Academy of Science, Vol. 1165, 2009, pp. 183-189. doi:10.1111/j.1749-6632.2009.04059.x
[12]	K. Teahon, S. Somasundaram, T. Smith, I. Menzies and I. Bjarnason, “Assessing the Site of Increased Intestinal Permeability in Coeliac and Inflammatory Bowel Disease,” Gut, Vol. 38, No. 6, 1996, pp. 864-869. doi:10.1136/gut.38.6.864
[13]	L. Miele, et al., “Increased Intestinal Permeability and Tight Junction Alterations in Nonalcoholic Fatty Liver Disease,” Hepatology, Vol. 49, No. 6, 2009, pp. 1877-1887. doi:10.1002/hep.22848
[14]	A. Parlesak, C. Schafer, T. Schutz, J. C. Bode and C. Bode, “Increased Intestinal Permeability to Macromolecules and Endotoxemia in Patients with Chronic Alcohol Abuse in Different Stages of Alcohol-Induced Liver Disease,” Journal of Hepatology, Vol. 32, No. 5, 2000, pp. 742-747. doi:10.1016/S0168-8278(00)80242-1
[15]	B. J. Ammori, et al., “Early Increase in Intestinal Permeability in Patients with Severe Acute Pancreatitis: Correlation with Endotoxemia, Organ Failure, and Mortality,” Journal of Gastrointestinal Surgery, Vol. 3, No. 3, 1999, pp. 252-261.doi:10.1016/S1091-255X(99)80067-5
[16]	H. Lennernas, “Human Intestinal Permeability,” Journal of Pharmaceutical Sciences, Vol. 87, No. 4, 1998, pp. 403-410. doi:10.1021/js970332a
[17]	M. G. Besselink, et al., “Intestinal Barrier Dysfunction in a Randomized Trial of a Specific Probiotic Composition in Acute Pancreatitis,” Annals of Surgery, Vol. 250, No. 5, 2009, pp. 712-719. doi:10.1097/SLA.0b013e3181bce5bd
[18]	G. M. Diepenhorst, et al., “Influence of Prophylactic Probiotics and Selective Decontamination on Bacterial Translocation in Patients Undergoing Pancreatic Surgery: A Randomized Controlled Trial,” Shock, Vol. 35, No. 1, 2011, pp. 9-16. doi:10.1097/SHK.0b013e3181ed8f17
[19]	T. Kanda, et al., “Intestinal Fatty Acid-Binding Protein Is a Useful Diagnostic Marker for Mesenteric Infarction in Humans,” Gastroenterology, Vol. 110, No. 2, 1996, pp. 339-343. doi:10.1053/gast.1996.v110.pm8566578
[20]	J. M. Lieberman, J. Sacchettini, C. Marks and W. H. Marks, “Human Intestinal Fatty Acid Binding Protein: Report of an Assay with Studies in Normal Volunteers and Intestinal Ischemia,” Surgery, Vol. 121, No. 3, 1997, pp. 335-342. doi:10.1016/S0039-6060(97)90363-9
[21]	A. Fasano, et al., “Zonulin, a Newly Discovered Modulator of Intestinal Permeability, and Its Expression in Coeliac Disease,” Lancet, Vol. 355, No. 9214, 2000, pp. 1518-1519. doi:10.1016/S0140-6736(00)02169-3
[22]	W. L. Wang, S. Uzzau, S. E. Goldblum and A. Fasano, “Human Zonulin, a Potential Modulator of Intestinal Tight Junctions,” Journal of Cell Science, Vol. 113, No. 24, 2000, pp. 4435-4440.
[23]	A. Tripathi, et al., “Identification of Human Zonulin, a Physiological Modulator of Tight Junctions, as Prehaptoglobin-2,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 39, 2009, pp. 16799-16804. doi:10.1073/pnas.0906773106
[24]	F. Lutgendorff, “Defending the Barrier,” Ph.D. Thesis, Universiteit Utrecht, Utrecht, 2009.
[25]	M. Lamprecht, et al., “Probiotic Supplementation Affects Markers of Intestinal Barrier, Oxidation, and Inflammation in Trained Men; A Randomized, Double-Blinded, Placebo-Controlled Trial,” Journal of the International Society of Sports Nutrition, Vol. 9, No. 1, 2012, p. 45. doi:10.1186/1550-2783-9-45
[26]	M. Viljanen, et al., “Probiotic Effects on Faecal Inflammatory Markers and on Faecal Iga in Food Allergic Atopic Eczema/Dermatitis Syndrome Infants,” Pediatric Allergy and Immunology, Vol. 16, No. 1, 2005, pp. 65-71. doi:10.1111/j.1399-3038.2005.00224.x
[27]	C. Alberda, et al., “Effects of Probiotic Therapy in Critically Ill Patients: A Randomized, Double-Blind, Placebo-Controlled Trial,” American Journal of Clinical Nutrition, Vol. 85, No. 3, 2007, pp. 816-823.
[28]	E. Garcia Vilela, et al., “Influence of Saccharomyces Boulardii on the Intestinal Permeability of Patients with Crohn’s Disease in Remission,” Scandanavian Journal of Gastroenterology, Vol. 43, No. 7, 2008, pp. 842-848. doi:10.1080/00365520801943354
[29]	M. Gotteland, S. Cruchet and S. Verbeke, “Effect of Lactobacillus Ingestion on the Gastrointestinal Mucosal Barrier Alterations Induced by Indometacin in Humans,” Alimentary and Pharmacology Therapy, Vol. 15, No. 1, 2001, pp. 11-17. doi:10.1046/j.1365-2036.2001.00898.x
[30]	Z. Liu, et al., “Randomised Clinical Trial: The Effects of Perioperative Probiotic Treatment on Barrier Function and Post-Operative Infectious Complications in Colorectal Cancer Surgery—A Double-Blind Study,” Alimentary Pharmacology & Therapeutics, Vol. 33, No. 1, 2011, pp. 50-63. doi:10.1111/j.1365-2036.2010.04492.x
[31]	C. E. McNaught, N. P. Woodcock, J. MacFie and C. J. Mitchell, “A Prospective Randomised Study of the Probiotic Lactobacillus Plantarum 299v on Indices of Gut Barrier Function in Elective Surgical Patients,” Gut, Vol. 51, No. 6, 2002, pp. 827-831. doi:10.1136/gut.51.6.827
[32]	B. S. Reddy, et al., “Randomized Clinical Trial of Effect of Synbiotics, Neomycin and Mechanical Bowel Preparation on Intestinal Barrier Function in Patients Undergoing Colectomy,” British Journal of Surgery, Vol. 94, No. 5, 2007, pp. 546-554. doi:10.1002/bjs.5705
[33]	Z. Stratiki, et al., “The Effect of a Bifidobacter Supplemented Bovine Milk on Intestinal Permeability of Preterm Infants,” Early Human Development, Vol. 83, No. 9, 2007, pp. 575-579.
[34]	J. W. Zhang, et al., “Preoperative Probiotics Decrease Postoperative Infectious Complications of Colorectal Cancer,” American Journal of Medical Science, Vol. 343, No. 3, 2012, pp. 199-205. doi:10.1097/MAJ.0b013e31823aace6
[35]	J. Karczewski, et al., “Regulation of Human Epithelial Tight Junction Proteins by Lactobacillus Plantarum in Vivo and Protective Effects on the Epithelial Barrier,” American Journal of Physiology and Gastrointestinal Liver Physiology, Vol. 298, No. 6, 2010, pp G851-G859. doi:10.1152/ajpgi.00327.2009
[36]	R. J. Boyle, F. J. Bath-Hextall, J. Leonardi-Bee, D. F. Murrell and M. L. Tang, “Probiotics for the Treatment of Eczema: A Systematic Review,” Clinical and Experimental Allergy, Vol. 39, No. 8, 2009, pp. 1117-1127. doi:10.1111/j.1365-2222.2009.03305.x
[37]	D. Jonkers, J. Penders, A. Masclee and M. Pierik, “Probiotics in the Management of Inflammatory Bowel Disease: A Systematic Review of Intervention Studies in Adult Patients,” Drugs, Vol. 72, No. 6, 2012, pp. 803-823. doi:10.2165/11632710-000000000-00000
[38]	P. Moayyedi, et al., “The Efficacy of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review,” Gut, Vol. 59, No. 3, 2010, pp. 325-332. doi:10.1136/gut.2008.167270
[39]	T. A. Sentongo, et al., “Intestinal Permeability and Effects of Lactobacillus rhamnosus Therapy in Children with Short Bowel Syndrome,” Journal of Pediatric Gastroenterology and Nutrition, Vol. 46, No. 1, 2008, pp. 41-47. doi:10.1097/01.mpg.0000304452.92175.f5
[40]	P. Gupta, H. Andrew, B. S. Kirschner and S. Guandalini, “Is Lactobacillus GG Helpful in Children with Crohn’s Disease? Results of a Preliminary, Open-Label Study,” Journal of Pediatric Gastroenterology and Nutrition, Vol. 31, No. 4, 2000, pp. 453-457. doi:10.1097/00005176-200010000-00024
[41]	E. Isolauri, M. Juntunen, T. Rautanen, P. Sillanaukee and T. Koivula, “A Human Lactobacillus Strain (Lactobacillus casei SP Strain GG) Promotes Recovery from Acute Diarrhea in Children,” Pediatrics, Vol. 88, No. 1, 1991, pp. 90-97.
[42]	B. Leber, et al., “The Influence of Probiotic Supplementation on Gut Permeability in Patients with Metabolic Syndrome: An Open Label, Randomized Pilot Study,” European Journal of Clinical Nutrition, Vol. 66, No. 10, 2012, pp. 1110-1115. doi:10.1038/ejcn.2012.103
[43]	B. Sharma, et al., “Role of Probiotics on Gut Permeability and Endotoxemia in Patients with Acute Pancreatitis: A Double-Blind Randomized Controlled Trial,” Journal of Clinical Gastroenterology, Vol. 45, No. 5, 2011, pp. 442-448. doi:10.1097/MCG.0b013e318201f9e2
[44]	C. Gore, et al., “Treatment and Secondary Prevention Effects of the Probiotics Lactobacillus paracasei or Bifidobacterium lactis on Early Infant Eczema: Randomized Controlled Trial with Follow-Up until Age 3 Years,” Clinical and Experimental Allergy, Vol. 42, No. 1, 2012, pp. 112-122. doi:10.1111/j.1365-2222.2011.03885.x
[45]	H. L. Qin, et al., “Effect of Lactobacillus plantarum Enteral Feeding on the Gut Permeability and Septic Complications in the Patients with Acute Pancreatitis,” European Journal of Clinical Nutrition, Vol. 62, No. 7, 2008, pp. 923-930. doi:10.1038/sj.ejcn.1602792
[46]	R. Francavilla, et al., “A Randomized Controlled Trial of Lactobacillus GG in Children with Functional Abdominal Pain,” Pediatrics, Vol. 126, No. 6, 2010, pp. e1445-e1452. doi:10.1542/peds.2010-0467
[47]	R. C. Anderson, A. L. Cookson, W. C. McNabb, W. J. Kelly and N. C. Roy, “Lactobacillus Plantarum DSM 2648 Is a Potential Probiotic That Enhances Intestinal Barrier Function,” FEMS Microbiology Letters, Vol. 309, No. 2, 2010, pp. 184-192. doi:10.1111/j.1574-6968.2010.02038.x
[48]	C. M. Chapman, G. R. Gibson and I. Rowland, “In Vitro Evaluation of Single- and Multi-Strain Probiotics: Inter-Species Inhibition between Probiotic Strains, and Inhibition of Pathogens,” Anaerobe, Vol. 18, No. 4, 2012, pp. 405-413. doi:10.1016/j.anaerobe.2012.05.004
[49]	H. M. Timmerman, C. J. Koning, L. Mulder, F. M. Rombouts and A. C. Beynen, “Monostrain, Multistrain and Multispecies Probiotics—A Comparison of Functionality and Efficacy,” International Journal of Food Microbiology, Vol. 96, No. 3, 2004, pp. 219-233. doi:10.1016/j.ijfoodmicro.2004.05.012
[50]	M. Nermes, J. M. Kantele, T. J. Atosuo, S. Salminen and E. Isolauri, “Interaction of Orally Administered Lactobacillus rhamnosus GG with Skin and Gut Microbiota and Humoral Immunity in Infants with Atopic Dermatitis,” Clinical and Experimental Allergy, Vol. 41, No. 3, 2011, pp. 370-377. doi:10.1111/j.1365-2222.2010.03657.x
[51]	C. J. O’Boyle, et al., “Alterations in Intestinal Barrier Function Do Not Predispose to Translocation of Enteric Bacteria in Gastroenterologic Patients,” Nutrition, Vol. 14, No. 4, 1998, pp. 358-362. doi:10.1016/S0899-9007(97)00488-7
[52]	M. Lamprecht and A. Frauwallner, “Exercise, Intestinal Barrier Dysfunction and Probiotic Supplementation,” Medical Sport Science, Vol. 59, 2013, pp. 47-56. doi:10.1159/000342169
[53]	E. J. Schiffrin, et al., “Probiotic Yogurt in the Elderly with Intestinal Bacterial Overgrowth: Endotoxaemia and Innate Immune Functions,” British Journal of Nutrition, Vol. 101, No. 7, 2009, pp. 961-966. doi:10.1017/S0007114508055591
[54]	M. A. van Nieuwenhoven, B. J. Geerling, N. E. Deutz, F. Brouns and R. J. Brummer, “The Sensitivity of the Lactulose/Rhamnose Gut Permeability Test,” European Journal of Clinical Investigations, Vol. 29, No. 2, 1999, pp. 160-165. doi:10.1046/j.1365-2362.1999.00421.x
[55]	F. Scaldaferri, M. Pizzoferrato, V. Gerardi, L. Lopetuso and A. Gasbarrini, “The Gut Barrier: New Acquisitions and Therapeutic Approaches,” Journal of Clinical Gastroenterology, Vol. 46, 2012, pp. S12-S17. doi:10.1097/MCG.0b013e31826ae849
[56]	D. R. Duerksen, C. Wilhelm-Boyles, R. Veitch, D. Kryszak and D. M. Parry, “A Comparison of Antibody Testing, Permeability Testing, and Zonulin Levels with Small-Bowel Biopsy in Celiac Disease Patients on a Gluten-Free Diet,” Digestive Disease Science, Vol. 55, No. 4, 2010, pp. 1026-1031. doi:10.1007/s10620-009-0813-5
[57]	A. Sapone, et al., “Zonulin Upregulation Is Associated with Increased Gut Permeability in Subjects with Type 1 Diabetes and Their Relatives,” Diabetes, Vol. 55, No. 5, 2006, pp. 1443-1449. doi:10.2337/db05-1593
[58]	K. Becker, T. Frieling and D. Haussinger, “Quantification of Fecal Alpha 1-Antitrypsin Excretion for Assessment of Inflammatory Bowel Diseases,” European Journal of Medical Research, Vol. 3, No. 1-2, 1998, pp. 65-70.
[59]	S. Y. Salim and J. D. Soderholm, “Importance of Disrupted Intestinal Barrier in Inflammatory Bowel Diseases,” Inflammatory Bowel Disease, Vol. 17, No. 1, 2011, pp. 362-381. doi:10.1002/ibd.21403
[60]	L. Biancone, et al., “Non-Invasive Techniques for Assessing Postoperative Recurrence in Crohn’s Disease,” Digestive Liver Diseases, Vol. 40, Suppl. 2, 2008, pp. S265-S270. doi:10.1016/S1590-8658(08)60536-8
[61]	K. Tiihonen, A. C. Ouwehand and N. Rautonen, “Effect of Overweight on Gastrointestinal Microbiology and Immunology: Correlation with Blood Biomarkers,” British Journal of Nutrition, Vol. 103, No. 7, 2009, pp. 1-9. doi:10.1017/S0007114509992807
[62]	J. Holland, et al., “Intraoperative Splanchnic Hypoperfusion, Increased Intestinal Permeability, Down-Regulation of Monocyte Class II Major Histocompatibility Complex Expression, Exaggerated Acute Phase Response, and Sepsis,” American Journal of Surgery, Vol. 190, No. 3, 2005, pp. 393-400. doi:10.1016/j.amjsurg.2005.03.038
[63]	Z. F. Tang, Y. B. Ling, N. Lin, Z. Hao and R. Y. Xu, “Glutamine and Recombinant Human Growth Hormone Protect Intestinal Barrier Function Following Portal Hypertension Surgery,” World Journal of Gastroenterology, Vol. 13, No. 15, 2007, pp. 2223-2228.
[64]	J. Brignardello, et al., “Pilot Study: Alterations of Intestinal Microbiota in Obese Humans Are Not Associated with Colonic Inflammation or Disturbances of Barrier Function,” Alimentary Pharmacology & Therapeutics, Vol. 32, No. 11-12, 2010, pp. 1307-1314. doi:10.1111/j.1365-2036.2010.04475.x
[65]	V. Rosenfeldt, et al., “Effect of Probiotics on Gastrointestinal Symptoms and Small Intestinal Permeability in Children with Atopic Dermatitis,” Journal of Pediatrics, Vol. 145, No. 5, 2004, pp. 612-616. doi:10.1016/j.jpeds.2004.06.068
[66]	B. Klarin, et al., “Lactobacillus Plantarum 299v Reduces Colonisation of Clostridium Difficile in Critically Ill Patients Treated with Antibiotics,” Acta Anaesthesiologica Scandinavica, Vol. 52, No. 8, 2008, pp. 1096-1102. doi:10.1111/j.1399-6576.2008.01748.x
[67]	J. Zeng, et al., “Clinical Trial: Effect of Active Lactic Acid Bacteria on Mucosal Barrier Function in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome,” Alimentary Pharmacology & Therapeutics, Vol. 25, No. 8, 2008 pp. 994-1002. doi:10.1111/j.1365-2036.2008.03818.x
[68]	L. A. Gonzalez-Hernandez, et al., “Synbiotic Therapy Decreases Microbial Translocation and Inflammation and Improves Immunological Status in HIV-Infected Patients: a Double-Blind Randomized Controlled Pilot Trial,” Nutrition Journal, Vol. 11, 2012, p. 90. doi:10.1186/1475-2891-11-90
[69]	P. K. Jain, C. E. Mcnaught, A. D. Anderson, J. Macfie and C. J. Mitchell, “Influence of Synbiotic Containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and Oligofructose on Gut Barrier Function and Sepsis in Critically Ill Patients: A Randomised Controlled Trial,” Clinical Nutrition, Vol. 23, No. 4, 2004, pp. 467-475. doi:10.1016/j.clnu.2003.12.002
[70]	C. E. Mcnaught, N. P. Woodcock, A. D. Anderson and J. Macfie, “A Prospective Randomised Trial of Probiotics in Critically Ill Patients,” Clinical Nutrition, Vol. 24, No. 2, 2005, pp. 211-219. doi:10.1016/j.clnu.2004.08.008
[71]	L. Galpin, et al., “Effect of Lactobacillus GG on Intestinal Integrity in Malawian Children at Risk of Tropical Enteropathy,” American Journal of Clinical Nutrition, Vol. 82, No. 5, 2005, pp. 1040-1045.
[72]	M. Schunter, et al., “Randomized Pilot Trial of a Synbiotic Dietary Supplement in Chronic HIV-1 Infection,” BMC Complementary and Alternative Medicine, Vol. 12, 2012, p. 84. doi:10.1186/1472-6882-12-84